Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-30 6:51 pm Purchase | 2024-12-26 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 39,709,850 31.900% | 16,929,507 (+74.32%) | Filing History |
| 2024-11-14 4:33 pm Sale | 2024-09-30 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 0 0.000% | -6,457,293 (Position Closed) | Filing History |
| 2024-02-14 4:17 pm Sale | 2024-02-14 | 13D | Vor Biopharma Inc. VOR | 5AM Ventures VI L.P. | 6,361,723 9.400% | -330,706 (-4.94%) | Filing History |
| 2024-02-14 4:08 pm Sale | 2023-12-31 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 6,457,293 9.500% | -20,706 (-0.32%) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 7,618,948 11.236% | -351,563 (-4.41%) | Filing History |
| 2023-08-11 5:05 pm Purchase | 2023-08-10 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 22,780,343 33.700% | 20,198 (+0.09%) | Filing History |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 6,477,999 9.900% | 4,149,505 (+178.21%) | Filing History |
| 2023-01-10 12:48 pm Purchase | 2023-01-09 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 7,970,511 12.141% | 4,789,048 (+150.53%) | Filing History |
| 2022-12-09 4:31 pm Purchase | 2022-12-07 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 22,760,145 34.800% | 11,628,845 (+104.47%) | Filing History |
| 2022-11-14 4:46 pm Purchase | 2022-11-10 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 11,131,300 28.780% | 10,327 (+0.09%) | Filing History |
| 2022-10-27 4:47 pm Purchase | 2022-10-17 | 13G | Vor Biopharma Inc. VOR | Paradigm Biocapital Advisors LP | 2,328,494 6.100% | 2,328,494 (New Position) | Filing History |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 3,181,463 8.531% | -753,775 (-19.15%) | Filing History |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 3,935,238 10.601% | 3,935,238 (New Position) | Filing History |
| 2021-02-19 4:35 pm Purchase | 2021-02-09 | 13D | Vor Biopharma Inc. VOR | 5AM Ventures VI L.P. | 6,692,429 18.000% | 6,692,429 (New Position) | Filing History |
| 2021-02-19 4:30 pm Purchase | 2021-02-09 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 11,120,973 30.000% | 11,120,973 (New Position) | Filing History |